We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+10.49%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$11.9B
AUM Growth
+$2.55B
Cap. Flow
+$1.81B
Cap. Flow %
15.19%
Top 10 Hldgs %
28.34%
Holding
1,181
New
44
Increased
774
Reduced
301
Closed
61

Sector Composition

Rank Sector Weight
1 Technology 34.81%
2 Financials 13.96%
3 Healthcare 11.37%
4 Energy 7.72%
5 Consumer Discretionary 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CI icon
226
Cigna
CI
$73.7B
$8.7M 0.07%
26,260
+9,939
+61% +$3.14M
NVR icon
227
NVR
NVR
$16.5B
$8.68M 0.07%
1,882
+232
+14% +$1.02M
KOS icon
228
Kosmos Energy
KOS
$1.6B
$8.65M 0.07%
1,359,789
+110,539
+9% +$690K
ALNY icon
229
Alnylam Pharmaceuticals
ALNY
$27.5B
$8.63M 0.07%
36,303
+3,411
+10% +$728K
DXCM icon
230
DexCom
DXCM
$31.5B
$8.57M 0.07%
75,696
-26,424
-26% -$2.9M
ALKS icon
231
Alkermes
ALKS
$8.22B
$8.57M 0.07%
328,018
+37,387
+13% +$895K
SM icon
232
SM Energy
SM
$7.8B
$8.56M 0.07%
245,899
+73,222
+42% +$3.04M
ISEE
233
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$8.53M 0.07%
398,356
+25,594
+7% +$546K
SWN
234
DELISTED
Southwestern Energy Company
SWN
$8.51M 0.07%
1,454,830
+417,868
+40% +$2.75M
NTRA icon
235
Natera
NTRA
$38.3B
$8.49M 0.07%
211,450
+80,512
+61% +$3.32M
APLS
236
DELISTED
Apellis Pharmaceuticals
APLS
$8.49M 0.07%
164,104
+61,532
+60% +$3.26M
RRC icon
237
Range Resources
RRC
$9.38B
$8.46M 0.07%
338,037
+83,046
+33% +$2.27M
IRWD icon
238
Ironwood Pharmaceuticals
IRWD
$696M
$8.44M 0.07%
681,012
+51,038
+8% +$579K
FOLD
239
DELISTED
Amicus Therapeutics
FOLD
$8.42M 0.07%
689,769
+83,009
+14% +$934K
TPL icon
240
Texas Pacific Land
TPL
$27.8B
$8.39M 0.07%
32,229
-6,930
-18% -$1.84M
VGK icon
241
Vanguard FTSE Europe ETF
VGK
$30.7B
$8.38M 0.07%
151,080
+11,448
+8% +$604K
CRK icon
242
Comstock Resources
CRK
$3.89B
$8.37M 0.07%
610,256
+187,853
+44% +$3.21M
DK icon
243
Delek US
DK
$4.16B
$8.34M 0.07%
308,799
+42,595
+16% +$1.26M
PRTA icon
244
Prothena Corp
PRTA
$425M
$8.34M 0.07%
138,353
+31,687
+30% +$1.86M
KEY icon
245
KeyCorp
KEY
$24.2B
$8.33M 0.07%
478,292
+5,723
+1% +$101K
ANSS
246
DELISTED
Ansys
ANSS
$8.31M 0.07%
34,400
-7,320
-18% -$1.7M
AR icon
247
Antero Resources
AR
$11.1B
$8.31M 0.07%
268,007
+70,082
+35% +$2.42M
SWTX
248
DELISTED
SpringWorks Therapeutics
SWTX
$8.28M 0.07%
318,425
+74,061
+30% +$1.82M
IONS icon
249
Ionis Pharmaceuticals
IONS
$8.6B
$8.27M 0.07%
218,979
+67,005
+44% +$2.82M
ORLY icon
250
O'Reilly Automotive
ORLY
$72.9B
$8.22M 0.07%
146,160
-41,025
-22% -$2.21M

Similar funds

Rafferty Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Rafferty Asset Management held 1,181 positions worth $11.9B, up 27% from $9.4B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Rafferty Asset Management deployed $1.81B of net new capital in Q4 2022, opening 44 new positions and adding to 774 existing holdings. Its largest new stake was Akero Therapeutics: 187,799 shares worth $10.3M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 38% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Microchip Technology, an estimated $12.3M trimmed.

  • Rafferty Asset Management's largest Q4 2022 buy was Akero Therapeutics: 187,799 shares worth $10.3M.
  • Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q4 2022, an estimated $294M increase.
  • Rafferty Asset Management's biggest Q4 2022 reduction was Microchip Technology, cutting an estimated $12.3M.
  • Rafferty Asset Management fully exited CONTINENTAL RESOURCES INC. in Q4 2022, selling an estimated $7.53M.
  • Rafferty Asset Management's ten largest holdings make up 28% of its $11.9B portfolio in Q4 2022.
  • Rafferty Asset Management opened 44 new positions and closed 61 in Q4 2022.
  • Rafferty Asset Management's portfolio value rose 27% quarter-over-quarter to $11.9B.

Based on Rafferty Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.